LEXX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Lexaria Bioscience Corp

Watchlist Manager

Watchlist

Price: 4.05 USD -38.64% Market Closed

Market Cap: $6.7m

	Lexaria Bioscience Corp NASDAQ:LEXX	CA
	American Resources Corp NASDAQ:AREC	US
V	Veradermics Inc NYSE:MANE	US
K	KLA Corp DUS:KLA	US
S	Sunko Ink Co Ltd TWSE:1721	TW
	Mitra Pinasthika Mustika Tbk PT IDX:MPMX	ID
W	Workday Inc XMUN:W7D	US
	Telkom Indonesia (Persero) Tbk PT OTC:TLKMF	ID
K	Kanishk Steel Industries Ltd BSE:513456	IN
	Verbio Vereinigte Bioenergie AG XETRA:VBK	DE
L	Lam Soon Thailand PCL SET:LST	TH
D	DTE Energy Co XMUN:DGY	US
	Propanc Biopharma Inc NASDAQ:PPCB	AU

Profitability Summary

Lexaria Bioscience Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

100%

Strong 3Y Average Gross Margin

97%

Gross Margin is Increasing

83% > 100%

Negative Operating Margin

-3 973%

Negative 3Y Average Operating Margin

-2 025%

Declining Operating Margin

-2 839% > -3 973%

Negative Net Margin

-3 986%

Negative 3Y Average Net Margin

-2 035%

Declining Net Margin

-2 896% > -3 986%

Negative Free Cash Flow Margin

-3 954%

Negative 3Y Average Free Cash Flow Margin

-1 894%

Declining Free Cash Flow Margin

-2 630% > -3 954%

Negative ROE

-150%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-663%

Declining ROIC

-438% > -598%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.